503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.77%
Some net income increase while ORCL is negative at -47.13%. John Neff would see a short-term edge over the struggling competitor.
-3.78%
Negative yoy D&A while ORCL is 16.06%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
147.37%
Some yoy growth while ORCL is negative at -960.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
141.56%
SBC growth while ORCL is negative at -70.26%. John Neff would see competitor possibly controlling share issuance more tightly.
86.10%
Less working capital growth vs. ORCL's 404.59%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
291.86%
AR growth well above ORCL's 248.89%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.29%
Negative yoy usage while ORCL is 1745.12%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-214.27%
Both negative yoy, with ORCL at -83.73%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-17.50%
Negative yoy CFO while ORCL is 41.18%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
36.12%
Some CapEx rise while ORCL is negative at -572.92%. John Neff would see competitor possibly building capacity while we hold back expansions.
81.93%
Acquisition spending well above ORCL's 94.31%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
17.70%
Some yoy expansion while ORCL is negative at -59.80%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-3.62%
Both yoy lines are negative, with ORCL at -18.81%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-1218.12%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
218.29%
Investing outflow well above ORCL's 65.65%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
107.02%
Stock issuance far above ORCL's 16.18%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-50.79%
We cut yoy buybacks while ORCL is 0.60%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.